Janini is a non-invasive prenatal test that screens for the most common fetal “trisomy” conditions; Down Syndrome (chr.21), Edwards Syndrome (chr. 18), Patau Syndrome (chr. 13) and Gender of the fetus. 

“Janini requires a simple blood draw from the mother and thus is completely safe to both mother and child”
Janini at biolab:

Results are available within 10 working days.

Non-invasive; no risk of miscarriage.

Test only requires a small sample of maternal blood as early as 10 weeks of pregnancy.

High specificity and sensitivity in the detection of trisomy conditions notably Down Syndrome.

Janini test Cannot be performed for the following categories : 
  • Women who are less than 10 weeks  pregnant.
  • Women with Chromosomal abnormalities
  • Women who have undergone one of the following treatments in the last 4 months : Blood Transfusion, Immunotherapy, Stem Cell Therapy, Transplantation and Radiation Therapy. 











Page Image

Copyright © biolab 2018, Developed by Tech Factory

Hit enter to search or ESC to close